Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2017.Apr.06

OBI-833, the cancer therapeutic vaccine, has met the primary safety indicators in Phase I clinical trial for US and Taiwan

2017.Mar.09

The board of directors have resolved not to distribute dividends

2017.Mar.09

Announcement by the Company's Board of Directors to convene the 2016 Annual General Shareholders' meeting

2017.Mar.09

OBI Pharma’s Board of Directors approves the announcement of the Company’s 2016 individual and consolidated financial statements

2017.Jan.26

Supplemental Information: OBI-822 was approved to enter a Phase III clinical trial by the China Food and Drug Administration (CFDA)

2017.Jan.25

OBI-822 was approved to enter a Phase III clinical trial by the China Food and Drug Administration (CFDA)

2017.Jan.23

OBI Pharma Inc. announces the change of Chief Operating Officer

2017.Jan.21

Clarification on the news article by Commercial Times

2017.Jan.11

Clarification on the news article by United Daily News E-Paper

2017.Jan.10

Clarification on the news article by Economic Daily News

News

Latest News

Events

Latest events